Evidence map›Paper›PMID 39182227›Full record

ArticleGut microbes

Age-associated temporal decline in butyrate-producing bacteria plays a key pathogenic role in the onset and progression of neuropathology and memory deficits in 3×Tg-AD mice.

Paula M Chilton, Smita S Ghare, Benjamin T Charpentier, Scott A Myers, Aakarsha V Rao, Joseph F Petrosino, Kristi L Hoffman, John C Greenwell, Neetu Tyagi, Jyotirmaya Behera and 9 more

Abstract read
In one paragraph

Article in Gut microbes. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Review
  14. Review
  15. Article
  16. Review
  17. Fecal short-chain fatty acids vary by sex and amyloid status.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Paula M ChiltonDepartment of Medicine, Division of Gastroenterology, Hepatology & Nutrition, University of Louisville School of Medicine, Louisville, KY, USA.ORCID 0000-0002-8749-0975
Smita S GhareDepartment of Medicine, Division of Gastroenterology, Hepatology & Nutrition, University of Louisville School of Medicine, Louisville, KY, USA.ORCID 0009-0005-9627-4843
Benjamin T CharpentierDepartment of Medicine, Division of Gastroenterology, Hepatology & Nutrition, University of Louisville School of Medicine, Louisville, KY, USA.ORCID 0000-0001-8855-5884
Scott A MyersDepartment of Medicine, Division of Gastroenterology, Hepatology & Nutrition, University of Louisville School of Medicine, Louisville, KY, USA.ORCID 0000-0002-9799-419X
Aakarsha V RaoDepartment of Medicine, Division of Gastroenterology, Hepatology & Nutrition, University of Louisville School of Medicine, Louisville, KY, USA.ORCID 0009-0001-7149-2562
Joseph F PetrosinoAlkek Center for Metagenomics and Microbiome Research, Department of Molecular Virology & Microbiology, Baylor College of Medicine, Houston, TX, USA.ORCID 0000-0002-4046-6898
Kristi L HoffmanAlkek Center for Metagenomics and Microbiome Research, Department of Molecular Virology & Microbiology, Baylor College of Medicine, Houston, TX, USA.ORCID 0000-0002-4497-120X
John C GreenwellDepartment of Medicine, Division of Gastroenterology, Hepatology & Nutrition, University of Louisville School of Medicine, Louisville, KY, USA.ORCID 0000-0002-9590-148X
Neetu TyagiDepartment of Physiology, University of Louisville School of Medicine, Louisville, KY, USA.ORCID 0000-0002-1789-0754
Jyotirmaya BeheraDepartment of Physiology, University of Louisville School of Medicine, Louisville, KY, USA.ORCID 0000-0003-2023-9900
Yali WangDepartment of Medicine, Division of Gastroenterology, Hepatology & Nutrition, University of Louisville School of Medicine, Louisville, KY, USA.ORCID 0009-0005-6628-5509
Lucy J SloanDepartment of Medicine, Division of Gastroenterology, Hepatology & Nutrition, University of Louisville School of Medicine, Louisville, KY, USA.ORCID 0000-0002-2778-7224
JingWen ZhangDepartment of Medicine, Division of Gastroenterology, Hepatology & Nutrition, University of Louisville School of Medicine, Louisville, KY, USA.ORCID 0009-0006-3173-6450
Christopher B ShieldsNorton Neuroscience Institute, 4915 Norton Healthcare Blvd, Louisville, KY, USA.ORCID 0009-0006-2263-2449
Gregory E CooperNorton Neuroscience Institute, 4915 Norton Healthcare Blvd, Louisville, KY, USA.ORCID 0009-0008-3401-911X
Leila GobejishviliDepartment of Medicine, Division of Gastroenterology, Hepatology & Nutrition, University of Louisville School of Medicine, Louisville, KY, USA.ORCID 0000-0001-8912-1834
Scott R WhittemoreDepartment of Anatomical Sciences & Neurobiology, University of Louisville School of Medicine, Louisville, KY, USA.ORCID 0000-0001-6437-7200
Craig J McClainDepartment of Medicine, Division of Gastroenterology, Hepatology & Nutrition, University of Louisville School of Medicine, Louisville, KY, USA.ORCID 0000-0002-7219-8939
Shirish S BarveDepartment of Medicine, Division of Gastroenterology, Hepatology & Nutrition, University of Louisville School of Medicine, Louisville, KY, USA.ORCID 0009-0008-7833-527X

Funding

Role of oxidized linoleic acid metabolites in the pathogenesis of alcoholic liver diseaseP20GM113226 · NIGMS · UNIVERSITY OF LOUISVILLE · PI GHARE, SMITA S · 2016 to 2025
$24.1M
The Role of Nutrition in the Development/Progression of Alcohol-Induced Organ InjuryP50AA024337 · NIAAA · UNIVERSITY OF LOUISVILLE · PI Xiang Zhang · 2016 to 2026
$17.9M
Role of Gut Microbial Dysbiosis and Aging on HIV-associated neurocognitive and brain dysfunctionR01AG061065 · NIA · UNIVERSITY OF LOUISVILLE · PI BARVE, SHIRISH S, COHEN, RONALD A · 2018 to 2022
$3.8M
Phosphodiesterase 4 mediated pathogenic mechanisms in alcohol associated liver diseaseR01AA029798 · NIAAA · UNIVERSITY OF LOUISVILLE · PI GOBEJISHVILI, LEILA · 2021 to 2025
$2.2M
Role of Gut Microbiome and DHA Deficiency in Alcohol Induced NeuroinflammationU01AA022618 · NIAAA · UNIVERSITY OF LOUISVILLE · PI BARVE, SHIRISH S · 2016 to 2020
$1.7M
Lipid metabolites can both potentiate and treat alcoholic hepatitisU01AA026936 · NIAAA · UNIVERSITY OF LOUISVILLE · PI JOSHI-BARVE, SWATI, MCCLAIN, CRAIG J. · 2018 to 2022
$1.2M
Inflammation Resolving Lipid Mediators: Novel Therapy for Alcohol AssociatedLiver DiseaseI01CX002219 · VA · LOUISVILLE VA MEDICAL MEDICAL CENTER · PI CRAIG J. MCCLAIN · 2023 to 2026
–
CSRD VA I01 CX002219NIAAA NIH HHS P50 AA024337NIAAA NIH HHS R01 AA029798NIAAA NIH HHS U01 AA022618NIAAA NIH HHS U01 AA026936NIA NIH HHS R01 AG061065NIGMS NIH HHS P20 GM113226
6 · The paper itself

Abstract

Alterations in the gut-microbiome-brain axis are increasingly being recognized to be involved in Alzheimer's disease (AD) pathogenesis. However, the functional consequences of enteric dysbiosis linking gut microbiota and brain pathology in AD progression remain largely undetermined. The present work investigated the causal role of age-associated temporal decline in butyrate-producing bacteria and butyrate in the etiopathogenesis of AD. Longitudinal metagenomics, neuropathological, and memory analyses were performed in the 3×Tg-AD mouse model. Metataxonomic analyses showed a significant temporal decline in the alpha diversity marked by a decrease in butyrate-producing bacterial communities and a concurrent reduction in cecal butyrate production. Inferred metagenomics analysis identified the bacterial acetyl-CoA pathway as the main butyrate synthesis pathway impacted. Concomitantly, there was an age-associated decline in the transcriptionally permissive acetylation of histone 3 at lysines 9 and 14 (H3K9/K14-Ac) in hippocampal neurons. Importantly, these microbiome-gut-brain changes preceded AD-related neuropathology, including oxidative stress, tau hyperphosphorylation, memory deficits, and neuromuscular dysfunction, which manifest by 17-18 months. Initiation of oral administration of tributyrin, a butyrate prodrug, at 6 months of age mitigated the age-related decline in butyrate-producing bacteria, protected the H3K9/K14-Ac status, and attenuated the development of neuropathological and cognitive changes associated with AD pathogenesis. These data causally implicate age-associated decline in butyrate-producing bacteria as a key pathogenic feature of the microbiome-gut-brain axis affecting the onset and progression of AD. Importantly, the regulation of butyrate-producing bacteria and consequent butyrate synthesis could be a significant therapeutic strategy in the prevention and treatment of AD.

Indexed as

Alzheimer DiseaseBacteriaButyratesDisease Models, AnimalDysbiosisGastrointestinal MicrobiomeMemory DisordersAnimalsBrainBrain-Gut AxisDisease ProgressionHippocampusMaleMiceMice, TransgenicButyratesAlzheimer’s diseasebutyrate-producing bacteriagut dysbiosisgut microbiomehistone acetylationmetagenomicstau hyperphosphorylationtributyrin

Identifiers

PMID39182227
PMCPMC11346541

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.